Tech Company Financing Transactions
VenatoRx Pharmaceuticals Funding Round
VenatoRx Pharmaceuticals closed a $3.4 million investment round on 12/5/2013. Backers included private investors.
Transaction Overview
Company Name
Announced On
12/5/2013
Transaction Type
Venture Equity
Amount
$3,419,051
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
30 Spring Mill Dr.
Malvern, PA 19355
USA
Malvern, PA 19355
USA
Phone
Website
Email Address
Overview
VenatoRx Pharmaceuticals is a disease-focused pharmaceutical company dedicated to the discovery and development of novel anti-infective agents.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Christopher Burns
Chief Medical Officer
Tim Henkel
Chief Operating Officer
Ezra Felker
VP - Bus. Development
Daniel Pevear
VP - Bus. Development
Luigi Xerri
Browse more venture capital transactions:
Prev: 12/5/2013: Snapsheet venture capital transaction
Next: 12/5/2013: BTI Systems venture capital transaction
Share this article
Where The Data Comes From
We do our best to record all VC transactions involving tech companies. VC investment data records reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs